Cancer research
– our focus areas

To focus our efforts and increase our impact, we have designed two umbrella focus areas under the themes Improved Patient Outcomes and Science of Prevention and Detection.

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) are excited to announce a unique opportunity for funding clinical trials for geriatric oncology patients. The goal of the program is to bring together experts in the field with the aim of making a significant impact on patient lives in less than 5 years.

Central research question: There is a critical unmet need to study pre-existing tools and appropriately use them to guide treatment in the geriatric population. The major theme of this program lies around a central research question which draws together five areas of interest under one umbrella.

Expected outcome: a joint publication to show how evidence-based assessments can be used to formulate treatments across different cancer types will have a bigger impact for the PIs and add more value to the field.  Individual projects can also lead to individual publications. 

Applications are invited from consortia of researchers, consisting of 5 PIs, one for each area of interest and one of whom is the program leader. The total budget for the clinical research aspect of the program is USD 2M (5 x USD 400,000), with an additional budget of USD 50,000 for program administration. Each PI is required to bring a minimum of USD 400,000 co-funding for their own topic. Further details can be found at www.risingtide-foundation.org

Call Opens: January 17, 2021

Information Webinar With Possibility For Networking And Collaboration Opportunities: February 17, 2021

Deadline for LOI applications: July 17, 2021

Interested applicants are encouraged to contact the team at grants@risingtide.ch for further information about the program or to find collaborators. 

Research proposals must be submitted through proposalCENTRAL

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.